Tf-PLCaPZ showed significant in vitro LN229 cell growth inhibition, Tf-PLCaPZ also showed anti-tumor activity in vivo in a U373MG xenograft model.120,121 These promising preclinical results make ZOL an exciting potential therapy for GBM. This evidence concerns the gene TF and glioblastoma.